|
|
|
| Effects of Simotang Combined with Bifidobacterium BB-12 on Intestinal Flora and Digestive Function in Children with Constipation |
| WANG Qingqing |
| The Maternal and Child Health Hospital of Changping District, Beijing 102200 |
|
|
|
|
Abstract 【Objective】To explore the effects of Simotang combined with Bifidobacterium BB-12 on intestinal flora and digestive function in children with constipation. 【Methods】A total of 100 children with constipation admitted to our hospital from July 2021 to July 2023 were selected and divided into the control group and the observation group by random number table method, with 50 cases in each group. The control group was treated with Simotang Oral Liquid, while the observation group was treated with Simotang combined with Bifidobacterium BB-12. The symptom improvement, anorectal manometry indices, gastrointestinal hormone levels and the number of intestinal flora were compared between the two groups before and after treatment. 【Results】After treatment, the defecation interval, defecation time, defecation pain score, abdominal pain and bloating symptom scores in both groups were lower than those before treatment, and the observation group was lower than the control group, with statistically significant differences (P<0.05). After treatment, the rectal maximum volume sensory threshold, maximum anal squeeze pressure and simulated defecation anal pressure in both groups were lower than those before treatment, and the observation group was lower than the control group, with statistically significant differences (P<0.05); there was no significant difference in rectal resting pressure between the two groups before and after treatment (P>0.05). After treatment, the serum levels of gastrin and motilin in both groups were lower than those before treatment, and the observation group was lower than the control group, with statistically significant differences (P<0.05); there was no significant difference in serum somatostatin and vasoactive intestinal peptide levels between the two groups before and after treatment (P>0.05). After treatment, the numbers of lactobacilli and bifidobacteria in both groups were higher than those before treatment, and the observation group was higher than the control group; the numbers of enterobacteria and staphylococci in both groups were lower than those before treatment, and the observation group was lower than the control group, with statistically significant differences (P<0.05). 【Conclusion】 Simotang combined with Bifidobacterium BB-12 can effectively improve intestinal flora imbalance in children and promote the recovery of gastrointestinal digestive function, which is worthy of clinical reference.
|
|
Received: 03 June 2024
|
|
|
|
|
|
[1] 张树成,白玉作. 儿童便秘的治疗手段及应用指征[J].临床小儿外科杂志,2020,19(1):12-17.
[2] 赵明宗,郜统勋,王旋,等.儿童便秘治疗的研究进展[J].江苏医药,2023,49(5):531-534.
[3] 李新民,杜永刚,潘树强,等. 四磨汤口服液治疗儿童功能性便秘随机双盲多中心临床试验[J].中医药导报,2020,26(13):88-91.
[4] 杜娟,徐莉,牟娅妮,等. 乳双歧杆菌Bb12辅助治疗儿童功能性便秘疗效分析[J].东南国防医药,2021,23(6):610-613.
[5] 中华中医药学会脾胃病分会. 便秘中医诊疗专家共识意见(2017)[J] .中医杂志, 2017, 58(15): 1345-1350.
[6] 占小兵,方斌,邓宝贵,等. 中医外治法治疗儿童便秘Meta分析[J].新中医,2022,54(15):15-22.
[7] 贺媛媛,贺陈龙,李雅然,等. 槐杞黄颗粒联合聚乙二醇4000散治疗儿童便秘疗效及对患儿肠道菌群、免疫功能的影响[J].药物评价研究,2020,43(4):729-733.
[8] 黄衔,钟志旭,林少斌,等.四磨汤联合聚乙二醇在便秘患者结肠镜前肠道准备的效果观察[J].现代消化及介入诊疗,2016,21(2):258-260.
[9] 陈佳,向建文,池秀芳,等. 四磨汤联合穴位按摩治疗早产儿喂养不耐受的临床观察[J].广州医药,2019,50(2):76-78.
[10] 邓孝智,谢晓丽. 双歧杆菌三联活菌联合乳果糖对儿童功能性便秘的疗效[J].中国微生态学杂志,2020,32(10):1154-1156.
[11] 方万红.四磨汤辅助治疗对儿童便秘对肠道菌群和消化功能影响[J].陕西中医,2019,40(3):364-367.
[12] 眭颖. 双歧杆菌Bb-12治疗新生儿喂养不耐受疗效观察[J].中国现代医生,2018,56(31): 43-46.
[13] 王立,张波.双歧三联活菌胶囊联合乳果糖治疗儿童功能性便秘对胃肠道功能与胃肠激素的影响[J].贵州医药,2018,42(6):713-715.
[14] 吴杰,王春蕾. 复方嗜酸乳杆菌片、四磨汤、多潘立酮联合治疗小儿消化不良的临床效果[J].临床医学研究与实践,2023,8(2):60-63. |
|
|
|
2025, Vol. 42 
